All Stories Page

Why We're MADE FOR THIS

Learn what we're doing to transform health care, prepare the next generation of leaders, and solve the world's greatest medical challenges.

Stories

Duke Science and Technology: Pyroptotic Cell Death
Duke's Ed Miao, MD, PhD, a professor in the Departments of Immunology, Molecular Genetics, and Biology, was the first to demonstrate that pyroptosis (cellular suicide) is real and clears intracellular bacteria. More basic science research is needed, however, to understand why pyroptosis can occur in normal, non-infected cells, which could be implicated for sepsis.
A Family Legacy for Duke Cancer
Ever since Duke Cancer Institute helped Meg Lindenberger survive breast cancer more than a decade ago, she and her husband, Bill, have been faithful supporters.
HOPE: Having Only Positive Expectations
In 2011, Katie Corun was in her third semester of nursing school in Maryland when she began having personality changes—moodiness and anger. Neither she nor her husband of seven months, Ron, or her mother, Kathy, could figure out what was going on.
Beating the Odds
Nicole McGuinness was 29 in December 2015 when she woke up already an hour late for her government relations job. She had blood on her shirt, and her tongue was swollen.
Bursting the Bubble
A new clinical program gets Duke medical students off campus and into the community to serve.
Duke Nursing Students Make a Difference in Guatemala
As students at Duke University School of Nursing, Lindsay Salisbury and Shelby Strockbine entered their third semester with a new perspective on the importance of global health and their roles as future nurses.
A Long Struggle

Eric Dziuban, MD’07, the Centers for Disease Control and Prevention’s country director for the southwest African nation of Namibia, was enjoying a weekend at the coast with his family when the call came. A Romanian couple who had recently arrived in the Namibian capital of Windhoek from Spain had fallen ill. Tests confirmed everyone’s fear: COVID-19 had finally come to Namibia.

A Detour Into Melanoma
Postdoctoral Fellow Binita Chakraborty, PhD was intrigued: in published analyses of large numbers of patients with melanoma (skin cancer) treated with an immunotherapy that is becoming standard of care, the treatment worked better in men than in women.